Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells.

Abstract:

:Solid tumors contain a subset of stem-like cells that are resistant to the cytotoxic effects of chemotherapy/radiotherapy, but their susceptibility to cytolytic T lymphocyte (CTL) effector mechanisms has not been well characterized. Using a panel of early-passage human brain tumor stem/initiating cell (BTSC) lines derived from high-grade gliomas, we show that BTSCs are subject to immunologic recognition and elimination by CD8(+) CTLs. Compared with serum-differentiated CD133(low) tumor cells and established glioma cell lines, BTSCs are equivalent with respect to expression levels of HLA class I and ICAM-1, similar in their ability to trigger degranulation and cytokine synthesis by antigen-specific CTLs, and equally susceptible to perforin-dependent CTL-mediated cytolysis. BTSCs are also competent in the processing and presentation of antigens as evidenced by the killing of these cells by CTL when antigen is endogenously expressed. Moreover, we show that CTLs can eliminate all BTSCs with tumor-initiating activity in an antigen-specific manner in vivo. Current models predict that curative therapies for many cancers will require the elimination of the stem/initiating population, and these studies lay the foundation for developing immunotherapeutic approaches to eradicate this tumor population.

journal_name

Cancer Res

journal_title

Cancer research

authors

Brown CE,Starr R,Martinez C,Aguilar B,D'Apuzzo M,Todorov I,Shih CC,Badie B,Hudecek M,Riddell SR,Jensen MC

doi

10.1158/0008-5472.CAN-09-2687

subject

Has Abstract

pub_date

2009-12-01 00:00:00

pages

8886-93

issue

23

eissn

0008-5472

issn

1538-7445

pii

0008-5472.CAN-09-2687

journal_volume

69

pub_type

杂志文章
  • Toxicity, elimination, and metabolism of 10-ethyl-10-deazaaminopterin in rats and dogs.

    abstract::10-Ethyl-10-deazaaminopterin (10-EdAM) is an antifolate compound with greater therapeutic activity than methotrexate against transplanted tumors in mice. When given weekly for 3 weeks, the 10% lethal dose in rats was 125 mg/kg (i.p.) and in dogs it was 2.5 mg/kg (i.v.). The major histopathological findings in intoxica...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fanucchi MP,Kinahan JJ,Samuels LL,Hancock C,Chou TC,Niedzwiecki D,Farag F,Vidal PM,DeGraw JI,Sternberg SS

    更新日期:1987-05-01 00:00:00

  • Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers.

    abstract::Thirty-seven endometrial cancers were subjected to an allelotype analysis in an attempt to identify chromosomal regions that are lost in a significant portion of tumors and to identify tumors characterized by replication errors. Thirty-nine highly polymorphic microsatellite markers representing all chromosomal arms, e...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Peiffer SL,Herzog TJ,Tribune DJ,Mutch DG,Gersell DJ,Goodfellow PJ

    更新日期:1995-05-01 00:00:00

  • In vivo efficacy of a novel inhibitor of selected signal transduction pathways including calcium, arachidonate, and inositol phosphates.

    abstract::Aberrant signal transduction has been implicated in malignant transformation, growth, and progression. This has led to the proposal to use inhibitors of signal transduction pathways to treat cancer. One approach to circumventing potential toxicity and improving efficacy would be to target pathways upon which cancer ce...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kohn EC,Sandeen MA,Liotta LA

    更新日期:1992-06-01 00:00:00

  • Skp2-Mediated Stabilization of MTH1 Promotes Survival of Melanoma Cells upon Oxidative Stress.

    abstract::MTH1 helps prevent misincorporation of ROS-damaged dNTPs into genomic DNA; however, there is little understanding of how MTH1 itself is regulated. Here, we report that MTH1 is regulated by polyubiquitination mediated by the E3 ligase Skp2. In melanoma cells, MTH1 was upregulated commonly mainly due to its improved sta...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-1965

    authors: Wang JY,Liu GZ,Wilmott JS,La T,Feng YC,Yari H,Yan XG,Thorne RF,Scolyer RA,Zhang XD,Jin L

    更新日期:2017-11-15 00:00:00

  • Formalizing an integrative, multidisciplinary cancer therapy discovery workflow.

    abstract::Although many clinicians and researchers work to understand cancer, there has been limited success to effectively combine forces and collaborate over time, distance, data, and budget constraints. Here we present a workflow template for multidisciplinary cancer therapy that was developed during the 2nd Annual Workshop ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-0310

    authors: McGuire MF,Enderling H,Wallace DI,Batra J,Jordan M,Kumar S,Panetta JC,Pasquier E

    更新日期:2013-10-15 00:00:00

  • Cellular sensitization to cis-diamminedichloroplatinum(II) by novel analogues of the protein kinase C activator lyngbyatoxin A.

    abstract::Protein kinase C (PKC) has been implicated in enhancing cellular sensitivity to cis-diamminedichloroplatinum(II) (CP). We have synthesized a series of novel analogues of lyngbyatoxin A (7-linalylindolactam V), a natural tumor promoter and a potent activator of PKC, and investigated the effects of these synthetic compo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Basu A,Kozikowski AP,Sato K,Lazo JS

    更新日期:1991-05-15 00:00:00

  • Impact of intertumoral heterogeneity on predicting chemotherapy response of BRCA1-deficient mammary tumors.

    abstract::The lack of markers to predict chemotherapy responses in patients poses a major handicap in cancer treatment. We searched for gene expression patterns that correlate with docetaxel or cisplatin response in a mouse model for breast cancer associated with BRCA1 deficiency. Array-based expression profiling did not identi...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-4201

    authors: Rottenberg S,Vollebergh MA,de Hoon B,de Ronde J,Schouten PC,Kersbergen A,Zander SA,Pajic M,Jaspers JE,Jonkers M,Lodén M,Sol W,van der Burg E,Wesseling J,Gillet JP,Gottesman MM,Gribnau J,Wessels L,Linn SC,Jonkers J,

    更新日期:2012-05-01 00:00:00

  • Oncogenicity of the developmental transcription factor Sox9.

    abstract::SOX9 [sex-determining region Y (SRY)-box 9 protein], a high mobility group box transcription factor, plays critical roles during embryogenesis and its activity is required for development, differentiation, and lineage commitment in various tissues including the intestinal epithelium. Here, we present functional and cl...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-3660

    authors: Matheu A,Collado M,Wise C,Manterola L,Cekaite L,Tye AJ,Canamero M,Bujanda L,Schedl A,Cheah KS,Skotheim RI,Lothe RA,López de Munain A,Briscoe J,Serrano M,Lovell-Badge R

    更新日期:2012-03-01 00:00:00

  • Total serum cholesterol and triglycerides and risk of breast cancer: a prospective study of 24,329 Norwegian women.

    abstract::The association between total serum cholesterol and triglycerides and the incidence rate of breast cancer has been examined in 242 incident cases of breast cancer that developed among 24,329 Norwegian women during 11-14 years of follow-up. At the time of lipid measurement they were between 35 and 51 years of age. Ther...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Vatten LJ,Foss OP

    更新日期:1990-04-15 00:00:00

  • Oncogene AEG-1 promotes glioma-induced neurodegeneration by increasing glutamate excitotoxicity.

    abstract::Aggressive tumor growth, diffuse tissue invasion, and neurodegeneration are hallmarks of malignant glioma. Although glutamate excitotoxicity is considered to play a key role in glioma-induced neurodegeneration, the mechanism(s) controlling this process is poorly understood. Astrocyte elevated gene-1 (AEG-1) is an onco...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-0782

    authors: Lee SG,Kim K,Kegelman TP,Dash R,Das SK,Choi JK,Emdad L,Howlett EL,Jeon HY,Su ZZ,Yoo BK,Sarkar D,Kim SH,Kang DC,Fisher PB

    更新日期:2011-10-15 00:00:00

  • Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells.

    abstract::Regulation of c-myc expression is known to be sensitive to a variety of mitogenic stimuli in various cell types. Since estrogen is a well documented mitogen of estrogen-responsive human breast cancer (HBC) cells, we studied the influence of estradiol and its antagonist tamoxifen on the expression of c-myc in HBC cell ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Dubik D,Dembinski TC,Shiu RP

    更新日期:1987-12-15 00:00:00

  • Transcriptional repression of telomerase RNA gene expression by c-Jun-NH2-kinase and Sp1/Sp3.

    abstract::Telomerase is essential for immortalization of most human cancer cells. Expression of the core telomerase RNA (hTR) and reverse transcriptase (hTERT) subunits is mainly regulated by transcription. However, hTR transcriptional regulation remains poorly understood. We previously showed that the core hTR promoter is acti...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1941

    authors: Bilsland AE,Stevenson K,Atkinson S,Kolch W,Keith WN

    更新日期:2006-02-01 00:00:00

  • Up-regulation of the error-prone DNA polymerase {kappa} promotes pleiotropic genetic alterations and tumorigenesis.

    abstract::It is currently widely accepted that genetic instability is key to cancer development. Many types of cancers arise as a consequence of a gradual accumulation of nucleotide aberrations, each mutation conferring growth and/or survival advantage. Genetic instability could also proceed in sudden bursts leading to a more d...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bavoux C,Leopoldino AM,Bergoglio V,O-Wang J,Ogi T,Bieth A,Judde JG,Pena SD,Poupon MF,Helleday T,Tagawa M,Machado C,Hoffmann JS,Cazaux C

    更新日期:2005-01-01 00:00:00

  • Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes.

    abstract::Epstein-Barr virus (EBV) is associated with Burkitt lymphoma, nasopharyngeal carcinoma, opportunistic lymphomas in immunocompromised hosts, and a fraction of gastric cancers. Aberrant promoter methylation accompanies human gastric carcinogenesis, though the contribution of EBV to such somatic methylation changes has n...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-1349

    authors: Matsusaka K,Kaneda A,Nagae G,Ushiku T,Kikuchi Y,Hino R,Uozaki H,Seto Y,Takada K,Aburatani H,Fukayama M

    更新日期:2011-12-01 00:00:00

  • Inhibition of protein isoprenylation and p21ras membrane association by dehydroepiandrosterone in human colonic adenocarcinoma cells in vitro.

    abstract::Treatment of mice and rats with the adrenal steroid, dehydroepiandrosterone (DHEA), protects against spontaneous and chemically induced tumors. The mechanism of the chemopreventive action of DHEA, however, remains uncertain. DHEA has been reported to inhibit cholesterol biosynthesis. Mevalonic acid constitutes the bas...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Schulz S,Nyce JW

    更新日期:1991-12-15 00:00:00

  • Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.

    abstract::The distribution and localization of a glioma-associated antigen defined by monoclonal antibody 81C6 has been examined using human cultured cell lines and tissues. Monoclonal antibody 81C6 was selected from a hybridoma fusion of spleen cells of mice immunized with the glial fibrillary acidic protein-positive human gli...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Bourdon MA,Wikstrand CJ,Furthmayr H,Matthews TJ,Bigner DD

    更新日期:1983-06-01 00:00:00

  • Combined treatment of pancreatic cancer with mithramycin A and tolfenamic acid promotes Sp1 degradation and synergistic antitumor activity.

    abstract::Mithramycin (MIT) and tolfenamic acid (TA) inhibit the activity of the transcription factor Sp1. In the present study, we investigated whether pancreatic cancer treatment with a combination of these compounds has a synergistic effect on Sp1 activity, tumor growth, and their underlying response mechanisms. Treatment of...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-3282

    authors: Jia Z,Gao Y,Wang L,Li Q,Zhang J,Le X,Wei D,Yao JC,Chang DZ,Huang S,Xie K

    更新日期:2010-02-01 00:00:00

  • Phospholipase A2 activation and autoinduction of tumor necrosis factor gene expression by tumor necrosis factor.

    abstract::Tumor necrosis factor (TNF) acts via a cell surface receptor to induce a variety of cellular events including cytolysis, differentiation, and mitogenesis. The mechanisms underlying the cell specific actions of TNF are not known. In the present study, postreceptor events associated with the autoinduction of TNF express...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Spriggs DR,Sherman ML,Imamura K,Mohri M,Rodriguez C,Robbins G,Kufe DW

    更新日期:1990-11-15 00:00:00

  • Changes in glutathione content and resistance to anticancer agents in human stomach cancer cells induced by treatments with melphalan in vitro.

    abstract::A clone of a human gastric carcinoma cell line was used to determine whether cells which had survived a treatment with Melphalan would express altered survival responses when treated again with this agent 1 week or more later. Cells were treated for 1 h each week with 2 micrograms/ml (99% lethal dose). After the first...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Barranco SC,Townsend CM Jr,Weintraub B,Beasley EG,MacLean KK,Shaeffer J,Liu NH,Schellenberg K

    更新日期:1990-06-15 00:00:00

  • Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: an introduction.

    abstract::Our laboratory has found genomic imprinting of a large genomic domain of human 11p15.5, identifying six imprinted genes within this domain: (a) insulin-like growth factor II (IGF-II), an important autocrine growth factor in a wide variety of malignancies; (b) H19, an untranslated RNA that is a putative growth suppress...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Feinberg AP

    更新日期:1999-04-01 00:00:00

  • LEO1 is regulated by PRL-3 and mediates its oncogenic properties in acute myelogenous leukemia.

    abstract::PRL-3, an oncogenic dual-specificity phosphatase, is overexpressed in 50% of acute myelogenous leukemia (AML) and associated with poor survival. We found that stable expression of PRL-3 confers cytokine independence and growth advantage of AML cells. However, how PRL-3 mediates these functions in AML is not known. To ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-2321

    authors: Chong PS,Zhou J,Cheong LL,Liu SC,Qian J,Guo T,Sze SK,Zeng Q,Chng WJ

    更新日期:2014-06-01 00:00:00

  • Depletion of adenosine diphosphate-ribosyl transferase activity in rat liver during exposure to N-2-acetylaminofluorene: effect of thiols.

    abstract::The exposure of rats to a feeding regimen containing N-2-acetylaminofluorene (2AAF) causes an accumulation of lesions on liver DNA and a progressive impairment in DNA repair capacity. We used the in vivo experimental model of Teebor and Becker (Cancer Res., 31:1-3, 1971) with the carcinogen given to rats during four c...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Cesarone CF,Scovassi AI,Scarabelli L,Izzo R,Orunesu M,Bertazzoni U

    更新日期:1988-07-01 00:00:00

  • Comparison of RNase T1 fingerprints of U1, U2, and U3 small nuclear RNA's of HeLa cells, human normal fibroblasts, and Novikoff hepatoma cells.

    abstract::To determine whether there are differences between the U1, U2, and U3 small nuclear RNA's of human cancer cells (HeLa cells) and human normal fibroblasts (IMR-90 cells), and between these uridine-rich small nuclear RNA's of human and Novikoff hepatoma cells, the cells were first incubated in Eagle's medium with [32P]P...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Nohga K,Reddy R,Busch H

    更新日期:1981-06-01 00:00:00

  • A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model.

    abstract::In cancer chemoprevention studies, the identification of better antitumor-promoting agents is highly desired because they may have a wider applicability against the development of clinical cancers. Both epidemiological and animal studies have suggested that microchemicals present in the diet and several herbs and plan...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lahiri-Chatterjee M,Katiyar SK,Mohan RR,Agarwal R

    更新日期:1999-02-01 00:00:00

  • Limitation of differential expression of HLA-A,B,C antigens on choriocarcinoma cell lines by messenger RNA for HLA heavy chain but not by beta 2-microglobulin.

    abstract::The relative amounts of HLA-A,B,C antigens, beta 2-microglobulin (beta 2m), and trophoblast antigens (Trop-1 and Trop-2) were determined on nine choriocarcinoma cell lines including seven lines of gestational origin and two lines of nongestational origin (from ovary and stomach) by quantitative immunofluorescence anal...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Kawata M,Sizer K,Sekiya S,Parnes JR,Herzenberg LA

    更新日期:1984-09-01 00:00:00

  • Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.

    abstract::[SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2-methyl-1,4- butane-diamine-N,N')platinum (CI-973) is a cisplatin analogue that is currently in clinical trial. Preclinically, CI-973 retained activity against L1210, P388, K562, and human ovarian carcinoma sublines resistant to cisplatin in vitro. CI-973 also retained ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Elliott WL,Roberts BJ,Howard CT,Leopold WR 3rd

    更新日期:1994-08-15 00:00:00

  • Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.

    abstract::Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD) could function as a cell surface sensor for cell density, controlling the transition between local cell proliferation and tissue invasion in melanoma progression. We have tested the hypothesis that progressive cell clustering controls the proteolytic cascad...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-0378

    authors: Lunter PC,van Kilsdonk JW,van Beek H,Cornelissen IM,Bergers M,Willems PH,van Muijen GN,Swart GW

    更新日期:2005-10-01 00:00:00

  • Effects of structural modifications of antitumor antibiotics (luzopeptins) on the interactions with deoxyribonucleic acid.

    abstract::Luzopeptins consist of two identical, substituted quinolines linked to a cyclic decadepsipeptide, with a 2-fold symmetry. Luzopeptin A, with two acetylated sites in its peptide ring, is active against several experimental animal tumor systems. Luzopeptin B (one acetylated site) is less active, and luzopeptin C (no ace...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Huang CH,Crooke ST

    更新日期:1985-08-01 00:00:00

  • Role of lipid transfer proteins in the abnormal lipid content of Morris hepatoma mitochondria and microsomes.

    abstract::The level of nonspecific lipid transfer protein in three Morris hepatomas of varying degrees of differentiation has been found to be less than 10% of the level in either host or control livers, whereas phosphatidylcholine transfer activity is slightly reduced for hepatomas compared to host livers (20 to 40%), though n...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Crain RC,Clark RW,Harvey BE

    更新日期:1983-07-01 00:00:00

  • HEPSIN inhibits cell growth/invasion in prostate cancer cells.

    abstract::Expression of HEPSIN, a type II transmembrane serine protease in prostate cancer (CaP), has been highlighted by several studies analyzing CaP-specific gene expression alterations by cDNA microarray. Evaluations of the biological functions of HEPSIN in CaP cells are warranted for better assessment of its utility as a b...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Srikantan V,Valladares M,Rhim JS,Moul JW,Srivastava S

    更新日期:2002-12-01 00:00:00